Article
Correlation between NGS panel-based mutation results and clinical information in colorectal cancer patients
1 Apr 2024
Abstract excerpt
Early mutation identification guides patients with colorectal cancer (CRC) toward targeted therapies. In the present study, 414 patients with CRC were enrolled, and amplicon-based targeted next-generation sequencing (NGS) was then performed to detect genomic alterations within the 73 cancer-related genes in the OncoAim panel. The overall mutation rate was 91.5 % (379/414). Gene mutations were detected in 38/73...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
